Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of ZD4054 vs Placebo in Hormone-Resistant Prostate Cancer with Bone Metastases
jRCT2080220534Phase 3
- Sponsor
- AstraZeneca
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in prostate cancer (PCa) and bone metastases comparing ZD4054 with Placebo (2 arms).
02
Drugs
zibotentan
03
Conditions
prostate cancer (PCa)bone metastases
Beyond the preview
Go deeper on jRCT2080220534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220534.